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ABSTRACT 
An atherogenic diet induces oxidative stress leading to hypercholesterolemia. This condition causes atherosclerosis followed 
by increased LDL and MDA. Sorghum tempeh contains fiber and antioxidants that can protectively improve LDL and MDA 
levels. Therefore, this research aims to determine the effect of sorghum tempeh on LDL and MDA levels in atherogenic  
diet-induced rats compared to sorghum flour. It used a randomized pre-post test with a control group design. The test subjects 
were 30 male Sprague Dawley rats, consisting of 6 normal conditioned rats (C1), and 24 that were induced by an atherogenic 
diet (C2, T1, T2, T3) for 2 weeks. Sorghum flour was administered at a dose of 4.095 g (T1) and the sorghum tempeh  
at 3.041 g (T2) and 6.081 g (T3) for 4 weeks. Furthermore, C2 was constantly induced through an atherogenic diet. Total 
cholesterol and LDL levels were then analyzed using the CHOD-PAP method, and MDA levels, using the ELISA method. 
Meanwhile, statistical analysis for these variables was carried out using IBM SPSS Statistics 21 software. The results showed 
that the administration of sorghum flour and tempeh significantly reduced total cholesterol, LDL, MDA levels in each group 
(p = 0.001). Furthermore, it showed that there was a significantly strong correlation between LDL and MDA levels before 
and after treatment (r = 0.610, r = 0.805, and p = 0.001). The administration of sorghum tempeh at a dose of 6.081 g caused 
the greatest reduction (∆) in LDL levels at -44.19 ±2.58 mg.dL-1, although, it was not the same as normal control. Meanwhile, 
sorghum flour at a dose of 4.095 g was the most influential in reducing MDA levels to the same as normal control with delta 
(∆) at -7.67 ±0.37 ng.mL-1. In conclusion, sorghum tempeh and flour were the most effective at reducing LDL and MDA 
levels, respectively. 
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INTRODUCTION 
 Atherosclerosis occurs due to a progressive plaque growth 
process and is characterized by hypercholesterolemia, 
abnormalities in the shape of the arterial walls, and 
increased inflammatory mediators such as IL-6, IL-10, and 
MCP-1 (Estruch et al., 2016). Moreover, the induction  
of an inflammatory process and a simultaneous increase  
in LDL in the tunica intima causes the formation of reactive 
oxygen species (ROS) (Salvayre, Negre-Salvayre and 
Camaré, 2016; Marchio et al., 2019). High intracellular 
levels of ROS are involved in the process of lipid 
peroxidation which produces secondary reactive products 
such as MDA (Papac-Milicevic, Busch and Binder, 2016). 
 Increased reactivity of MDA causes endothelial damage 
and modifies LDL, which leads to changes in cellular 
response (Papac-Milicevic, Busch, and Binder, 2016). 
Meanwhile, an increase in the levels of LDL in blood 
plasma causes the formation of atheroma plaque, which 
would develop into cardiovascular disease (Ratnasari, 
Santosa and Rachmawati, 2018). Various studies have 
used mice induced by an atherogenic diet as models  
of atherosclerosis. These mice experience an increase in the 
accumulation of fat in their blood vessels leading  
to abnormal signal transduction in organs, oxidative stress, 
lipotoxicity, and organ dysfunction. This affects the activity 
of transcription factors in lipid metabolism in the heart (Lee 
et al., 2017). 
 One of the treatments of atherosclerosis is through the 
provision of fermented food (Şanlier, Gökcen and Sezgin, 
2019). Moreover, Indonesia is known to produce tempeh, 
the fermented food made from soybeans (Hartanti, 
Rahayu and Hidayat, 2015). Sorghum is a cereal that 
contains high fiber and antioxidants, however, it still has 
low food value (Espitia-Hernández et al., 2020). 
Furthermore, this cereal has been used as a raw material for 
the production of tempeh which was tested in atherogenic 
diet-induced rats. Sorghum tempeh (100 g) contains  
134.49% energy, 15.20% carbohydrates, 6.75% protein, 
5.21% fat, 66.40% water, 0.15% ash, 68.57% starch 
digestibility, 63.32% protein digestibility, 52.21% 
antioxidants, 5.92% total dietary fiber, 0.56% soluble 
dietary fiber, and 5.63% insoluble fiber. 
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 Sorghum tempeh could be produced through the following 
process. First, sorghum is soaked for 12 hours, boiled until 
it reaches a softer texture, and then left to cool, Furthermore, 
tempeh yeast which contains Rizhopus oligosporus is added 
to start the fermentation process (Hartanti, Rahayu and 
Hidayat, 2015). The resultant mold produces various 
protease enzymes with proteolytic activity, which makes 
sorghum tempeh easier to digest (Endrawati and 
Kusumaningtyas, 2017). Moreover, the fermentation 
process lasts for 60 hours and leads to the formation  
of β-glucosidase enzymes, which produce flavanone, 
flavonols, and aglycone isoflavones (Salazar-López et al., 
2018; Verni, Verardo and Rizzello, 2019). The final stage 
involves blanching for 5 minutes to stop the microbial 
activity (Tian et al., 2018). 
 The advantages of products fermented by Rhizopus 
oligosporus were proven in other similar studies. Quinoa 
seed extract fermented by this fungi had increased 
antioxidant enzymes, such as superoxide dismutase (SOD) 
and glutathione peroxidase (GSHPx) which help to prevent 
peroxidative damage (Matsuo, 2005; Hur et al., 2018). 
Furthermore, in line with the research on soybean and 
gembus tempeh, the results of yeast fermentation  
by Rhizopus spp was an increase in SOD enzyme which 
could reduce MDA levels (Harun, Susanto and Rosidi, 
2017; Kurniasari et al., 2017). 
 Sorghum tempeh has the potential as an antioxidant and 
anti-cholesterol agent, which could repair oxidative stress 
damage (Pisoschi and Pop, 2015; Dykes, 2019). Moreover, 
fermented sorghum could reduce oxidative stress through 
the fermentation effect of its fiber. This fiber modulates the 
intestinal microbiota to improve immune function through 
the production of short-chain fatty acid (SCFA) (Ohira, 
Tsutsui and Fujioka, 2017). SCFA reduces inflammation 
that triggers oxidative stress by suppressing T helper cells, 
neutrophils, macrophages, and cytotoxic activity in natural 
killer cells (Tan, Norhaizan and Liew, 2018; Hu et al., 
2020). 
 Sorghum tempeh also plays a role in controlling serum 
cholesterol. This is because the cellulose synthase-like (Csl) 
gene in the soluble fiber, (1,3;1,4)-β-glucan has the 
potential to increase fiber levels, which would reduce apoB-
100 and LDL (Ermawar et al., 2015; Ho et al., 2016). 
Additionally, fiber fermented by the intestinal microbiota 
produces SCFA, which influences lipid metabolism through 
transport and de novo synthesis to lower plasma cholesterol 
levels (Chen et al., 2018). 
 From the above, the aim of the research, which is to prove 
the protective ability of sorghum tempeh to reduce MDA 
and LDL levels. Sorghum flour which was used  
as a comparison is sorghum seeds that were processed into 
flour without fermentation. These seeds were mashed with 
a grinder to achieve a powdery texture then sifted until they 
became soft. The previous study has been shown that 
sorghum flour improving lipid profile and MDA levels  
in rats (Silva et al., 2020; Zakaria et al., 2011). Besides, 
the flour (100 g) contains 315.11% energy, 69.75% 
carbohydrates, 8.12% protein, 1.31% fat, 10.55% water, 
1.47% ash, 80.50% starch digestibility, 78.70% protein 
digestibility, 75.18% antioxidants, 8.79% total dietary fiber, 
0.94% soluble dietary fiber, and 7.85% insoluble dietary 
fiber. 
Scientific Hypothesis 
 Sorghum tempeh decreases LDL and MDA levels  
in atherogenic diet-induced rats more effect than sorghum 
flour. Moreover, the levels of these variables were strong 
correlations before and after treatment. 
 
MATERIAL AND METHODOLOGY 
Samples 
 This study used white sorghum (Figure 1). The grain was 
soaked in water at a ratio of 1:3 for 12 hours and then boiled 
for 10 minutes. After that, the addition of the tempeh yeast 
at 0.25 g for every 100 g of white sorghum was carried out 
after the sorghum had cooled. The mixture was then 
incubated at room temperature (29 ±1 °C) for 60 hours. 
Subsequently, the sorghum tempeh was blanched at 90 °C 
for 5 minutes (Figure 2). 
 Sorghum flour was used as a comparison for sorghum 
tempeh and was produced by processing sorghum seeds 
without fermentation. The white sorghum was purred using 
a grinder to achieve a powdery texture and subsequently 
sieved with 70 mesh (Figure 3). Moreover, the dosage of 
sorghum tempeh and flour was based on human fiber needs, 
which is 20 g.d-1. This amount was then converted to 200 g 
of body weight for the rats. Finally, the dosage for T1, T2, 
T3-groups at 4.095 g, 3.041 g, and 6.081 g, respectively. 
Chemicals 
 Two milliliters of blood were obtained from the retro-
orbital plexus of the rats for total cholesterol (mg.dL-1), 
LDL (mg.dL-1), and MDA (ng.mL-1) serum were assessed 
in PSPG UGM Yogyakarta Laboratory, Indonesia. 
Animal and Biological Material 
 This study used male Sprague Dawley rats supplied  
by PSPG UGM Yogyakarta Animal Laboratory, Indonesia. 
The white sorghum was produced by Sedana Panen 
Sejahtera Ltd., Jombang, Indonesia. The tempeh yeast was 
produced by Aneka Fermentasi Industri Ltd., Bandung, 
Indonesia. 
Instrument 
 The weights and diet consumed of the rats were measured  
by Digital Camry EK5055 Max.5 kg d = 1 g. Total 
cholesterol levels were tested using the Cholesterol FS (10`) 
5 x 25 mL.1 x 3 mL-1 STD. Meanwhile, LDL levels were 
tested using the LDL Precipitant 250 mL Kit. Finally, MDA 
levels were ascertained using the General Malondialdehyde 
ELISA Kit (MDA) 96 wells (IP). The kits of these tests were 
supplied by Khairos Jaya Sejahtera Ltd., Yogyakarta, 
Indonesia. 
Laboratory Methods 
 Total cholesterol and LDL levels were tested according  
to the CHOD-PAP method (WHO/IFCC). MDA levels were 
tested according to the ELISA method (ISO 9001:2008; 
ISO 13485:2003). 
Description of the Experiment 
 This study used a true experimental design with  
a randomized pre-post test control group design. 
Furthermore, it was conducted at the PSPG UGM 
Yogyakarta Animal Laboratory from October-December 
2020. 
 
Potravinarstvo Slovak Journal of Food Sciences 
Volume 15 664  2021 
 
 
 Figure 1 Preparation of Sorghum Tempeh and Flour. 
 
 
 Figure 2 Sorghum Tempeh. 
 
 
 Figure 3 Sorghum Flour. 
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 Sample preparation: 
 The inclusion criteria were male Sprague Dawley rats aged 
2 months and weighing 150 – 200 g, that were in a healthy 
condition during the acclimatization period. Moreover, the 
acclimatization period was 1 week and aimed to get the 
animals acquainted with the type of feed and new way  
of life. The atherogenic criteria were based on the 
hypercholesterolemic condition of the rats (total cholesterol 
levels more than 100 ml.dL-1). Meanwhile, the dropout 
criteria were rats that their body weight decreased  
to <150 g during the adaptation period and those that died 
during the study. 
 Number of samples analyzed: 
 There were 30 male Sprague Dawley rats. Additionally, 
they were divided by simple random sampling into five 
groups, namely C1, C2, T1, T2, and T3-groups, and were 
housed individually. The cage room had an ambient 
temperature of 28 – 32 oC with a lighting cycle of 12 hours 
dark and 12 hours light. Furthermore, the rat feeds used 
were standard (Comfeed AD II) and atherogenic feeds 
(Table 1). Assessment of diet consumed was based on the 
weight of feed given minus the weight of the remaining feed. 
 The rats in C2, T1, T2, and T3-groups were induced using 
an atherogenic diet for 2 weeks. Moreover, this feed was 
given at 20 g.d-1 and drinking water ad libitum. C1-group 
was in a normal condition as only the standard feed  
at 20 g.d-1 and drinking water ad libitum was given therein. 
For the remaining groups, they received interventions for  
4 weeks in a sonde, where the T1 group received sorghum 
flour at a dose of 4.095 g, while T2 and T3-groups received 
the tempeh at doses of 3.041 g and 6.081 g, respectively. 
The treatment groups were also given standard feed  
at 15 g.d-1 and drinking water ad libitum. Finally, C1-group 
was maintained at normal conditions, while C2-group was 
continuously induced using an atherogenic diet until the end 
of the research. 
 Number of repeated analyses: 
 The blood was obtained from the retro-orbital plexus  
of the rats for total cholesterol, LDL, and MDA serum was 




 Data analysis was carried out using IBM SPSS Statistics 
21 software. Furthermore, data normality was tested using 
the Shapiro-Wilk test. Bivariate analysis was used  
to analyze the levels of total cholesterol, LDL, and MDA 
through Paired t-test when they were normally distributed. 
Meanwhile, when the data was not normal, the Wilcoxon 
Signed Ranks test was used. The differences in the influence 
of the conditions of C1, C2, T1, T2, T3-groups  
on bodyweight, weights of rat feed consumption, and total 
cholesterol, LDL, and MDA levels were analyzed using the 
One Way Anova test when the data were normally 
distributed and homogeneous. However, in a condition 
where the data were not normally distributed or not 
homogeneous, used the Kruskal Wallis test. The correlation 
test used for the levels of LDL and MDA was the Pearson 
test when the data were normally distributed, however, 
when not normally distributed the Rank Spearman test was 
used. Finally, the value of significance in the study was  
p <0.05. 
 
RESULTS AND DISCUSSION 
 The bodyweight of the rats at the beginning and end of the 
study did not differ significantly between the groups  
(p = 0.383 and p = 0.136). After the provision of the 
treatment products in T1, T2, and T3-groups, there was  
a significant difference between the groups (p = 0.010), that 
the treatment groups were the same as the normal control  
(p = 0.793, p = 0.189, and p = 0.057), and significant 
difference compared to the atherogenic diet induction 
control (p = 0.006 and p = 0.001) except for T1-group  
(p = 0.091). Additionally, the mean body weight in T1-
group was lower compared to that of the atherogenic diet 
induction control. Table 2 shows the significant difference 
in delta (∆) between the groups after treatment (p = 0.001), 
where the biggest change was in the T1-group  
at +18.83 ±13.00 g. 
 The mean weight percentage of the feed consumed in the 
groups during the induction period with an atherogenic diet 
was not significantly different (p = 0.836), while during the 
treatment period there was a significant difference  
(p = 0.009). Moreover, based on further tests, T1, T2,  
T3-groups had no significant difference in the weights 
percentage of feed consumed (p >0.05). Table 3 shows that 
the T3-group from the induction to treatment period had  
a higher average percentage of feed consumed compared  
to the other two treatment groups, at 90.65% and 97.81%. 
 Table 4 shows that the levels of total cholesterol before 
treatment in T1, T2, and T3-groups were significantly 
different from the normal control (C1) (p = 0.001) and the 
same as the atherogenic diet induction control group  
(C2) (p = 0.852, p = 0.729, and p = 0.498). There was  
a significant increase in cholesterol total levels in the  
C2-group (p = 0.001), while in C1-group, there was the least 
change (∆), at +2.01 ±1.36 mg.dL-1 among all groups. 
Furthermore, the three treatments with their respective 
doses significantly reduced atherogenic parameters  
by lowering total cholesterol (p = 0.001) and were 
significantly different from the atherogenic diet induction 
control (p = 0.001), but still not the same as the normal 
control (p = 0.001). Meanwhile, the biggest change  
(∆) occurred in T3-group at -80.55 ±5.79 mg.dL-1. 
 LDL levels in T1, T2, and T3-groups after induction with 
the atherogenic diet was significantly different from normal 
control (C1) (p = 0.001), however, not significantly 
different from atherogenic diet induction control (C2)  
(p = 0.947, p = 1.000, p = 0.833). Table 5 shows that after 
the administration of the treatments, there was a significant 
decrease in the LDL levels (p = 0.001) across the groups, 
differ to the atherogenic diet induction control (p = 0.001) 
although, they were still significantly different from normal 
control (p = 0.001, p = 0.001, p = 0.008). When viewed from 
delta (∆), it shows that the T3-group (sorghum tempeh  
a dose of 6.081 g) had the greatest influence, namely  
-44.19 ±2.58 mg.dL-1 when compared to the other two 
treatments. The treatment in this group had the same effect 
as in the T1-group (p = 0.265), but a significantly different 
effect compared to the T2-group (p = 0.020). Meanwhile, 
the treatment in T1 and T2-groups had the same effect  
(p = 0.225). 
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 MDA levels in the T1, T2, T3-groups after induction were 
also significantly different compared to normal control  
(C1) (p = 0.001, p = 0.006, p = 0.004) and not significantly 
different from atherogenic diet induction control (C2)  
(p = 0.818, p = 0.818, p = 0.896). Additionally, after the 
administration of the treatment, there was a significant 
decrease in MDA levels (p <0.05) across the groups and the 
levels were also significantly different from the atherogenic 
diet induction control (p = 0.001, p = 0.018) except for  
T3-group (p = 0.238). The administration of sorghum 
tempeh at the dose of 6.081 g caused the smallest effect  
(∆) among the three treatments at -3.97 ±0.33 ng.mL-1, 
which was still the same as the atherogenic diet induction 
control (p = 0.238), however, significantly different from 
normal control (p = 0.001). Likewise, sorghum tempeh  
at a dose of 3.041 g did not have the same effect as normal 
control (p = 0.018). The administration of sorghum flour  
at a dose of 4.095 g had the most effect on improving MDA 
levels to a similar level as normal control (p = 0.238) with 
the largest delta (∆), namely -7.67 ±0.37 ng.mL-1. 
Statistically, the treatment in T1-group had a significantly 
different effect compared to the T3-group (p = 0.018) and 
the same effect as in the T2-group (p = 0.237). Meanwhile, 
the treatment in T2 and T3-groups had the same effect  
(p= 0.237) (Table 6). 
 Table 7 shows that LDL and MDA levels had a strong 
positive correlation before treatment, meaning that the 
higher the LDL levels, the higher the MDA levels (p = 0.001, 
r = 0.610). After the treatment period, LDL and MDA levels 
had a strong positive correlation, because the lower the LDL 
levels, the lower the MDA levels (p = 0.001, r = 0.805). 
 The rats induced with an atherogenic diet for 2 weeks had 
significantly increased total cholesterol levels, which could 
lead to atherosclerosis, with levels more than 100 mg.dL-1 
in rats (Zárate et al., 2016).  
 
 Table 1 Composition of Standard and Atherogenic Feed. 
Standard Feed Atherogenic Feed 
  
12% water, 51% carbohydrates, 15% crude protein, 3-
7% crude fat, 6% crude fiber, 7% ash, 0.55% 
phosphorus, 0.9 – 1.1 % calcium. 
12% water, 51% carbohydrates, 15% crude protein, 3-7% 
crude fat, 6% crude fiber, 7% ash, 0.55% phosphorus, 0.9 – 
1.1 % calcium, cholic acid, pure cholesterol. 
 
 
 Table 2 Bodyweight of Rats. 
Groups 
Mean ± SD (g) 
The Beginning 
of The Study 
After 
Atherogenic 
Diet Induction  
∆1 The End of The Study ∆2 
C1 (normal control) 189 ±10.81 215.83 ±9.37 26.83 ±7.94 252.33 ±19.56 36.50 ±17.23 
C2 (atherogenic diet 
induction control) 192 ±13.67 229.83 ±18.57 37.83 ±10.63 288.17 ±38.65 58.33 ±24.79 
T1 (sorghum fluor a dose 
of 4.095 g) 192.83 ±12.90 229.33 ±11.86 36.50 ±8.41 248.17 ±13.83
a,c 18.83 ±13.00 
T2 (sorghum tempeh a 
dose of 3.041 g) 191.17 ±6.37 231 ±11.95 39.83 ±9.45 237.50 ±15,29
 a,b 6.50 ±8.46 
T3 (sorghum tempeh a 
dose of 6.081 g) 181.50 ±8.34 219.17 ±6.74 37.67 ±3.45 230.50 ±8.74
a,b 11.33 ±8.73 
p 0.3831 0.1361 0.0911 0.0102* 0.0011* 
Note: ∆1 = Bodyweight of after atherogenic diet induction – Bodyweight of the beginning of the study; ∆2 = Bodyweight 
of the end of the study – Bodyweight of after atherogenic diet induction; 1One Way ANOVA Test; 2Kruskal Wallis Test; 
aNot significantly different from normal control; bSignificantly different from atherogenic diet induction control; cNot 
significantly different from atherogenic diet induction control. *Significant (p <0.05). 
 
 
 Table 3 Weights of Rat Feed Consumption. 
Groups 
Mean ± SD (g) 
Atherogenic Diet Induction 
Period Treatment Period
 
C1 (normal control) 17.94 ±1.43 (89.71%) 17.82 ±0.71 (89.11%) 
C2 (atherogenic diet induction control) 17.49 ±1.87 (87.45%) 16.66 ±2.07 (83.31%) 
T1 (sorghum fluor a dose of 4.095 g) 17.56 ±1.36 (87.79%) 14.19 ±0.63 (94.61%)a 
T2 (sorghum tempeh a dose of 3.041 g) 17.18 ±1.47 (85.90%) 14.24 ±0.39 (94.95%)a 
T3 (sorghum tempeh a dose of 6.081 g) 18.13 ±1.55 (90.65%) 14.67 ±0.40 (97.81%)a 
p 0.8361 0.0092* 
Note: 1One Way ANOVA Test; 2Kruskal Wallis Test; aThe comparison between T1, T2, and T3-groups was not 
significantly different. *Significant (p <0.05). 
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 Table 4 Changes in Blood Cholesterol Total Levels Before and After Treatment. 
Groups 
Mean ± SD (mg.dL-1)  
Before Treatment After Treatment ∆ p 
C1 (normal control) 83.22 ±2.36 85.23 ±2.61 +2.01 ±1.36 0.0151* 
C2 (atherogenic diet induction control) 192.01 ±4.78 222.75 ±3.91 +30.74 ±6.28 0.0011* 
T1 (sorghum fluor a dose of  
4.095 g) 189.61 ±4.19
a,c 122.88 ±3.50a,b  -66.74 ±5.50 0.0011* 
T2 (sorghum tempeh a dose of 3.041 g) 189.04 ±4.84a,c 133.60 ±3.28a,b -55.45 ±6.44 0.0011* 
T3 (sorghum tempeh a dose of 6.081 g) 188.13 ±4.96a,c 107.58 ±2.69a,b -80.55 ±5.79 0.0011* 
p 0.0012* 0.0012* 0.0012  
Note: 1Paired t Test; 2One Way ANOVA Test; aSignificantly different from normal control; bSignificantly different from 




 Table 5 Changes in Blood LDL Levels Before and After Treatment. 
Groups 
Mean ± SD (mg.dL-1)  
Before 
Treatment After Treatment ∆
 p 
C1 (normal control) 23.88 ±2.50 25.44 ±3.20 +1.56 ±1.18 0.0231* 
C2 (atherogenic diet induction control) 76.12 ±1.38 85.37 ±1.30 +9.24 ±1.69 0.0011* 
T1 (sorghum fluor a dose of 4.095 g) 76.93 ±1.27a,c 39.95 ±2.48a,b -36.98 ±3.16d 0.0011* 
T2 (sorghum tempeh a dose of 3.041 g) 76.36 ±2.04a,c 52.27 ±2.89a,b -24.09 ±3.70d 0.0011* 
T3 (sorghum tempeh a dose of 6.081 g) 74.97 ±2.08a,c 30.78 ±2.04a,b -44.19 ±2.58d 0.0011* 
p 0.0012* 0.0012* 0.0013*  
Note: 1Paired t Test; 2One Way ANOVA Test; 3Kruskal Wallis Test; aSignificantly different from normal control; 
bSignificantly different from atherogenic diet induction control; cNot significantly different from atherogenic diet 
induction control. dThe comparison was significant (T2 and T3-groups), was not significant (T1 and T2-groups, T1 and 
T3-groups). *Significant (p <0.05). 
 
 
 Table 6 Changes in Blood MDA Levels Before and After Treatment. 
Groups 
Mean ± SD (ng.mL-1)  
Before 
Treatment After Treatment ∆ p
 
C1 (normal control) 1.00 ±0.22 1.03 ±0.02 +0.02 ±0.01 0.0011* 
C2 (atherogenic diet induction control) 9.36 ±0.51 9.65 ±0.40 +0.29 ±0.14 0.0042* 
T1 (sorghum fluor a dose of 4.095 g) 9.36 ±0.28a,d 1.69 ±0.18b,c -7.67 ±0.37e 0.0011* 
T2 (sorghum tempeh a dose of 3.041 g) 9.29 ±0.21a,d 2.95 ±0.18a,c -6.34 ±0.32e 0.0281* 
T3 (sorghum tempeh a dose of 6.081 g) 9.30 ±0.29a,d 5.33 ±0.47a,d -3.97 ±0.33e 0.0011* 
P 0.0073* 0.0013* 0.0013*  
Note: 1Paired t Test; 2Wilcoxon Signed Ranks Test; 3Kruskal Wallis Test; aSignificantly different from normal 
control; bNot significantly different from normal control; cSignificantly different from atherogenic diet induction 
control; dNot significantly different from atherogenic diet induction control; eThe comparison was significant (T1 
and T3-groups), was not significant (T1 and T2-groups, T2 and T3-groups).*Significant (p <0.05). 
 
 
Table 7 Correlation between LDL and MDA Levels. 
LDL and MDA p r 
Before Treatment1 0.001* 0.610a 
After Treatment2 0.001* 0.805a 
Note: 1Rank Spearman;2Pearson; aStrong Correlation.*Significant (p <0.05). 
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 Moreover,  these characteristics describe atherosclerotic 
conditions and require intervention (NCEP, 2001). 
Induction with the atherogenic diet contains high 
cholesterol and cholic acid continued for up to 6 weeks in 
C2-group and caused the increase of cholesterol total, LDL, 
and MDA levels (Yamada et al., 2017). 
 Cholesterol abnormalities lead to changes in cholesterol 
content, including LDL (Pirillo et al., 2018). Moreover, 
LDL levels have a strong positive correlation with MDA 
levels and this proves that LDL contributes to the oxidative 
stress process, which is marked by increased MDA (Tsikas, 
2017). Other studies stated that increased LDL and MDA 
have a positive correlation to vascular inflammation which 
is a clinical marker of atherosclerotic plaque, evaluated with 
18F-FDG PET/CT (Kaida et al., 2014). LDL accumulates 
in artery walls causing monocytes to differentiate into 
macrophages and secrete inflammatory mediators such  
as Interferon-γ (IFN- γ) and tumor necrosis factor (TNF). 
This inflammation triggers oxidative stress through the 
activity of myeloperoxidase, lipoxygenase, and ROS 
(Gisterå and Hansson, 2017). 
 In this research, to tackle the impact of the development  
of atherosclerosis, sorghum tempeh and flour were used  
at different doses calculated based on the needs of human 
fiber and converted to 200 g of body weight of rats. The 
results showed a significant decrease in LDL levels 
followed by total cholesterol and MDA levels. 
 When traced from fiber content, the cellulose synthase-like 
(Csl) gene insoluble fiber (1,3; 1,4) -β-glucan in sorghum 
tempeh and flour has the potential to increase sorghum fiber 
content (Ermawar et al., 2015; Ho et al., 2016). The 
digested fiber in the colon, fermented by the intestinal 
microbiota produces SCFA. SCFA is divided into three 
substrates regulating plasma cholesterol reduction, namely 
acetate, propionate, and butyrate. Cholesterol synthesis  
is reduced in the liver due to decreased acetyl CoA by the 
inhibition of 3-hydroxyl-3-methylglutaryl-CoA (HMG-CoA) 
reductase. This increases the activity of the LDL receptor  
to reduce LDL levels (Feingold, 2000; Chen et al., 2018). 
 The group treated with sorghum tempeh a dose of 6.081 g 
(T3) had the most reduced LDL levels, although it was not 
maximal until it was close to normal control. However,  
it was lower than the atherogenic diet induction control. 
This is because at this dose, the fiber needs were satisfied 
and the percentage of group feed consumption was greater 
than the two other treatments >90%. Other studies also 
suggested that food fermented by Rhizopus oligosporus has 
the potential as an anti-hyperlipidemia agent to inhibit 
cholesterol through SCFA in animals fed with high-fat diets 
(Huang et al., 2018; Dimidi et al., 2019). 
 MDA is a parameter of oxidative stress in atherosclerosis 
(Czerska et al., 2015). The results showed that its levels 
significantly decreased with treatment using sorghum 
tempeh and flour. When viewed from the antioxidant 
content in sorghum, 3-deoxyanthocyanidin is a phenolic 
that affects reducing oxidative stress (Afify et al., 2012; 
Ramatoulaye et al,. 2016). Sorghum tempeh and flour both 
contain antioxidants at 52.21% and 75.18%. Meanwhile, 
high antioxidant activity reduces oxidative stress  
by increasing the antioxidant enzymes such as SOD and 
GSHPx (Akyol et al., 2017; Hasanuzzaman et al., 2020). 
 Sorghum flour at a dose of 4.095 g (T1) was the most 
effecive at reducing MDA levels to the same as normal 
control. This is possible because the antioxidant content  
of this flour is greater than that of sorghum tempeh. 
Moreover, the flour does not go through immersion  
or heating processes such as in the process of producing 
sorghum tempeh, thus it is more likely to maintain greater 
amounts of antioxidants (Liu et al., 2020). In line with 
similar studies tested on rats, it was stated that sorghum 
flour increased lymphocyte proliferation activity leading  
to higher SOD enzyme, CAT, and GSHPx activity. 
Therefore, the balance of antioxidants could be improved 
and MDA levels decreased (Zakaria et al., 2011). 
 LDL and MDA levels had a strong positive correlation 
after treatment. This shows that efforts to reduce LDL levels 
also caused a reduction in MDA levels. Similar studies 
where sorghum was administered showed similar results. 
The administration of sorghum kafirin inhibited the increase 
in serum LDL in hyperlipidemic rats (Cruz et al., 2015). 
Likewise, fermented sorghum reduced LDL levels  
in hypercholesterolemic rats (Laleye et al., 2016). Another 
study where sorghum rice was administered along with 
black rice to rats with induced hypercholesterolemia in their 
liver for 12 weeks showed a significant reduction in hepatic 
LDL (Liu, Huang and Pei., 2021). The same was true for 
interventions with fermented foods against MDA. There 
was a decrease in serum LDL and MDA in the liver with the 
intervention using fermented tea in rats induced by high fat 
(Sun et al., 2019). Additionally, fermented tempeh also 
reduced MDA levels in rats induced by an atherogenic diet 
for 4 weeks (Kurniasari et al., 2017). 
 
 The changes in body weight of the rats at the end of the 
study in T2 and T3-groups were not different from the 
normal control, although, they were lower than those of the 
atherogenic diet-induced control. Therefore, sorghum 
tempeh in the treatment of atherosclerosis following the 
method used in this study had the protective ability to repair 




 The rats induced with the atherogenic diet that received the 
intervention of sorghum tempeh and flour had decreased 
LDL and MDA levels. Furthermore, sorghum tempeh  
a dose of 6.081 g was the most effect at reducing LDL levels, 
although not the same effect as sorghum flour at reducing 
MDA levels. Sorghum tempeh and flour could be functional 
food for atherosclerosis treatment. 
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